To see the other types of publications on this topic, follow the link: Gene therapy.

Journal articles on the topic 'Gene therapy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Gene therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Goyal, Anjana, Reena Doomra, Aayushi Garg, and Kruthiventi Hemalata. "CRISPR Gene Therapy in Dentistry." Asian Pacific Journal of Health Sciences 6, no. 2 (June 2019): 182–83. http://dx.doi.org/10.21276/apjhs.2019.6.2.26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gawthorpe, Paula. "Gene Therapy Gene Therapy." Nursing Standard 17, no. 33 (April 30, 2003): 29. http://dx.doi.org/10.7748/ns2003.04.17.33.29.b25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

M. Gordon, Erlinda, Joshua R. Ravicz, Sant P. Chawla, Christopher W. Szeto, Sant P. Chawla, Michael A. Morse, Frederick L. Hall, and Erlinda M. Gordon. "CCNG1 oncogene: a novel biomarker for cancer therapy /gene therapy." Cancer Research and Cellular Therapeutics 5, no. 4 (August 30, 2021): 01–09. http://dx.doi.org/10.31579/2640-1053/090.

Full text
Abstract:
Background: Metastatic cancer is associated with an invariably fatal outcome. However, DeltaRex-G, a tumor-targeted retrovector encoding a gene-edited dominant-negative CCNG1 inhibitor gene, has induced long term (>10 years) survival of patients with chemo-resistant metastatic pancreatic adenocarcinoma, malignant peripheral nerve sheath tumor, osteosarcoma, B-cell lymphoma, and breast carcinoma. Objective: To evaluate the level of CCNG1 expression in tumors as a potential biomarker for CCNG1 (Cyclin G1-blocking) inhibitor therapy. Methods: CCNG1 RNA expression levels that were previously measured as part of whole genome molecular profiling of tumors (TCGA, N=9161), adjacent “tissues” (TCGA, N=678) and GTEx normal tissues (N=7187) across 22 organ sites were analyzed. Differential expression of CCNG1 and Ki-67 in primary (N= 9161) vs metastatic (N= 393) tumors were also compared in primary (N=103) vs. metastatic (N=367) skin cancers (i.e., melanoma). Statistical Analysis: To detect systematically differential expression of CCNG1 and Ki-67 expression between populations (e.g. tumor vs. normal), unpaired Student's t-tests were performed. Results: Enhanced CCNG1 RNA and Cyclin G1 protein expression were noted in tumors compared to normal analogous counterparts, and CCNG1 expression correlated significantly with that of Ki-67. Moreover, CCNG1 expression tended to be higher than that of Ki-67 in metastatic vs primary tumors. Conclusions: Taken together with the emerging Cyclin G1 / Cdk / Myc / Mdm2 / p53 Axis governing Cancer Stem Cell Competence, this supportive data indicates: (1) CCNG1 expression is frequently enhanced in tumors when compared to their normal analogous counterparts, (2) CCNG1 and Ki-67 expressions are higher in metastatic vs primary tumors, (3) CCNG1 expression is significantly correlated with that of Ki-67, and (4) CCNG1 may actually be a stronger prognostic marker of stem cell competence, chemo-refractoriness, and EMT/metastasis than Ki-67. Phase 2 studies are planned to identify patients most likely to respond favorably to CCNG1 inhibitor therapy.
APA, Harvard, Vancouver, ISO, and other styles
4

Sose, Mr Aadesh S., and Mr Pramod M. Bhosale. "A Review on Gene Therapy for Cancer." International Journal of Research Publication and Reviews 4, no. 4 (April 2023): 3058–63. http://dx.doi.org/10.55248/gengpi.4.423.36713.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Gene therapy." Inpharma Weekly &NA;, no. 1161 (October 1998): 12. http://dx.doi.org/10.2165/00128413-199811610-00018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Gene therapy." Inpharma Weekly &NA;, no. 1184 (April 1999): 8. http://dx.doi.org/10.2165/00128413-199911840-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Peroutka, Christina, and Joann Bodurtha. "Gene Therapy." Pediatrics in Review 41, no. 11 (November 2020): 606–8. http://dx.doi.org/10.1542/pir.2019-0224.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

&NA;. "Gene therapy." Inpharma Weekly &NA;, no. 1120 (January 1998): 4. http://dx.doi.org/10.2165/00128413-199811200-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Whartenby, Katharine A., Aizen J. Marrogi, and Scott M. Freeman. "Gene Therapy." Drugs 50, no. 6 (December 1995): 951–58. http://dx.doi.org/10.2165/00003495-199550060-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Williamson, Robert. "Gene therapy." Australian Prescriber 20, no. 3 (July 1, 1997): 72–73. http://dx.doi.org/10.18773/austprescr.1997.062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Fibison, Wendy J. "GENE THERAPY." Nursing Clinics of North America 35, no. 3 (September 2000): 757–72. http://dx.doi.org/10.1016/s0029-6465(22)02515-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Nerkar, A. G., and G. S. Chakraborthy. "Gene therapy." Current Trends in Pharmacy and Pharmaceutical Chemistry 3, no. 3 (July 15, 2021): 15–18. http://dx.doi.org/10.18231/j.ctppc.2021.005.

Full text
Abstract:
Gene therapy is used to correct defective genes in order to cure a disease or help your body better fight disease. Gene therapy is the introduction, removal or change in genetic material specifically DNA or RNA into the cells of a patient to treat a specific disease. Disease is caused to mutation. Genes influence all from the color of our hair to immune system, but genes are not built correctly. Targets of the gene therapy causing diseases. Gene therapy uses section of DNACurrently gene therapy is being tested only for disease that have no. other cures. Interest area of this review covers introduction, history, DNA transfer, Types of gene therapy, working of therapy, techniques, Delivery system, strategies, technique challenges, risks, gene introduction site and clinical applications of gene therapy.
APA, Harvard, Vancouver, ISO, and other styles
13

&NA;. "Gene therapy." Drugs & Therapy Perspectives 7, no. 9 (May 1996): 6–8. http://dx.doi.org/10.2165/00042310-199607090-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

High, Katherine A., and Maria G. Roncarolo. "Gene Therapy." New England Journal of Medicine 381, no. 5 (August 1, 2019): 455–64. http://dx.doi.org/10.1056/nejmra1706910.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Steinberg, Gary K. "Gene Therapy." Neurosurgery 44, no. 2 (February 1, 1999): 253. http://dx.doi.org/10.1097/00006123-199902000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Rutka, James T. "Gene Therapy." Neurosurgery 44, no. 2 (February 1, 1999): 253. http://dx.doi.org/10.1097/00006123-199902000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Nemirovsky, Alexander, and Vladimir Zelman. "Gene Therapy." Neurosurgery 44, no. 2 (February 1, 1999): 253. http://dx.doi.org/10.1097/00006123-199902000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

&NA;. "Gene therapy." Reactions Weekly &NA;, no. 987 (February 2004): 9–10. http://dx.doi.org/10.2165/00128415-200409870-00023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Verma, Inder M. "Gene Therapy." Scientific American 263, no. 5 (November 1990): 68–84. http://dx.doi.org/10.1038/scientificamerican1190-68.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Baum, BJ. "Gene therapy." Oral Diseases 20, no. 2 (December 26, 2013): 115–18. http://dx.doi.org/10.1111/odi.12211.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Scheller, Erica L., Luis G. Villa-Diaz, and Paul H. Krebsbach. "Gene Therapy." Journal of Craniofacial Surgery 23, no. 1 (January 2012): 333–37. http://dx.doi.org/10.1097/scs.0b013e318241dc11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Drugan, Arie, Orlando J. Miller, and Mark I. Evans. "Gene Therapy." Fetal Diagnosis and Therapy 2, no. 4 (1987): 232–41. http://dx.doi.org/10.1159/000263322.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Mavilio, Fulvio, and Claudio Bordignon. "Gene therapy." Nature 362, no. 6418 (March 1993): 284. http://dx.doi.org/10.1038/362284b0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Morris, Jonathan. "Gene Therapy." American Biology Teacher 75, no. 2 (February 1, 2013): 139. http://dx.doi.org/10.1525/abt.2013.75.2.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Scully, Sean P. "Gene Therapy:." Clinical Orthopaedics and Related Research 379 (October 2000): S55—S58. http://dx.doi.org/10.1097/00003086-200010001-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Spallone, P. "Gene therapy." BMJ 305, no. 6848 (August 1, 1992): 315. http://dx.doi.org/10.1136/bmj.305.6848.315-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Badiavas, Evangelos V., and Vincent Falanga. "Gene Therapy." Journal of Dermatology 28, no. 4 (April 2001): 175–92. http://dx.doi.org/10.1111/j.1346-8138.2001.tb00116.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

SHAPIRO, LARRY J. "Gene Therapy." Pediatric Research 33, no. 4 (1993): 321–22. http://dx.doi.org/10.1203/00006450-199333040-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

STROHMAN, RICHARDC. "Gene therapy." Nature 355, no. 6362 (February 1992): 667. http://dx.doi.org/10.1038/355667c0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Trent, Ronald J. A. "Gene therapy." Heart, Lung and Circulation 9, no. 1 (May 2000): 43. http://dx.doi.org/10.1046/j.1444-2892.2000.0007b.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Kay, M. A., D. Liu, and P. M. Hoogerbrugge. "Gene therapy." Proceedings of the National Academy of Sciences 94, no. 24 (November 25, 1997): 12744–46. http://dx.doi.org/10.1073/pnas.94.24.12744.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Beutler, Ernest. "Gene therapy." Biology of Blood and Marrow Transplantation 5, no. 5 (October 1999): 273–76. http://dx.doi.org/10.1016/s1083-8791(99)70001-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Mhashilkar, Abner, Sunil Chada, Jack A. Roth, and Rajagopal Ramesh. "Gene therapy." Biotechnology Advances 19, no. 4 (July 2001): 279–97. http://dx.doi.org/10.1016/s0734-9750(01)00063-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Brody, Herb. "Gene therapy." Nature 564, no. 7735 (December 2018): S5. http://dx.doi.org/10.1038/d41586-018-07639-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Kmiec, Eric. "Gene Therapy." American Scientist 87, no. 3 (1999): 240. http://dx.doi.org/10.1511/1999.3.240.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Yaron, Yuval, Ralph L. Kramer, Mark P. Johnson, and Mark I. Evans. "GENE THERAPY." Obstetrics and Gynecology Clinics of North America 24, no. 1 (March 1997): 179–99. http://dx.doi.org/10.1016/s0889-8545(05)70296-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Birnstiel, Max L. "Gene therapy." European Review 4, no. 04 (October 1996): 335. http://dx.doi.org/10.1017/s1062798700002118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Trempe, James P. "Gene therapy." Biochemical Education 25, no. 4 (October 1997): 246–47. http://dx.doi.org/10.1016/s0307-4412(97)87549-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Baird, P. A. "GENE THERAPY." Lancet 333, no. 8643 (April 1989): 902. http://dx.doi.org/10.1016/s0140-6736(89)92896-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Bauer, Daniel E., and Donald B. Kohn. "Gene Therapy." Hematology/Oncology Clinics of North America 31, no. 5 (October 2017): i. http://dx.doi.org/10.1016/s0889-8588(17)30117-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Tzeng, Edith, Larry L. Shears, Michael T. Lotze, and Timothy R. Billiar. "Gene therapy." Current Problems in Surgery 33, no. 12 (December 1996): 961–1041. http://dx.doi.org/10.1016/s0011-3840(05)80020-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Steffin, David H. M., Emily M. Hsieh, and Rayne H. Rouce. "Gene Therapy." Advances in Pediatrics 66 (August 2019): 37–54. http://dx.doi.org/10.1016/j.yapd.2019.04.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Vile, Richard G. "Gene therapy." Current Biology 8, no. 3 (January 1998): R73—R75. http://dx.doi.org/10.1016/s0960-9822(98)70049-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Vogelzang, Robert L. "Gene Therapy." Journal of Vascular and Interventional Radiology 11, no. 2 (February 2000): 59. http://dx.doi.org/10.1016/s1051-0443(00)70033-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Sharp, David. "Gene therapy." Lancet 337, no. 8752 (May 1991): 1277–78. http://dx.doi.org/10.1016/0140-6736(91)92938-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Wood, E. J. "Gene therapy." Biochemical Education 24, no. 3 (July 1996): 181. http://dx.doi.org/10.1016/0307-4412(96)82519-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Geddes, Duncan M. "Gene therapy." Lancet 348, no. 9038 (November 1996): 1367–68. http://dx.doi.org/10.1016/s0140-6736(05)65410-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

TAKAKU, Fumimaro. "Gene Therapy." Internal Medicine 32, no. 4 (1993): 273. http://dx.doi.org/10.2169/internalmedicine.32.273.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Bhattacharya, Alok. "Gene Therapy." Current Science 114, no. 03 (February 10, 2018): 432. http://dx.doi.org/10.18520/cs/v114/i03/432-433.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Heslop, Helen. "Gene therapy." Cytotherapy 5, no. 3 (2003): 189. http://dx.doi.org/10.1080/14653240310001280.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography